Terrie Curran - Sep 9, 2021 Form 4 Insider Report for Myovant Sciences Ltd. (MYOV)

Role
Director
Signature
/s/ Matthew Lang, Attorney-in-fact
Stock symbol
MYOV
Transactions as of
Sep 9, 2021
Transactions value $
-$86,961
Form type
4
Date filed
9/13/2021, 04:11 PM
Previous filing
Sep 3, 2021
Next filing
Nov 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Options Exercise $37.1K +4.85K $7.65 4.85K Sep 9, 2021 Direct
transaction MYOV Common Shares Sale -$124K -4.85K -100% $25.58 0 Sep 9, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYOV Stock Option (Right to Buy) Options Exercise $0 -4.85K -48.02% $0.00 5.25K Sep 9, 2021 Common Shares 4.85K $7.65 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 trading plan.
F2 The shares were sold at prices ranging from $25.42 to $25.72. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Fully vested.